We are live on
!
Find out more
ACM
Ashford Capital Management Portfolio holdings
AUM
$809M
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+10.63%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.15%
5 Year Est. Return
+109.93%
10 Year Est. Return
+1,281.08%
AUM
$898M
AUM Growth
+$46.6M
(+5.5%)
Cap. Flow
-$1.9M
Cap. Flow
% of AUM
-0.21%
Top 10 Holdings %
Top 10 Hldgs %
37.38%
Holding
117
New
15
Increased
24
Reduced
44
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dutch Bros
BROS
|
+$10.2M |
| 2 |
VIA
Via Transportation Inc
VIA
|
+$9.14M |
| 3 |
VOXR
Vox Royalty Corp
VOXR
|
+$8.78M |
| 4 |
Porch Group
PRCH
|
+$8.11M |
| 5 |
Cellebrite
CLBT
|
+$6.83M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ligand Pharmaceuticals
LGND
|
+$8.64M |
| 2 |
CYBR
CyberArk
CYBR
|
+$6.19M |
| 3 |
AXON
Axon Enterprise
AXON
|
+$5.67M |
| 4 |
Atlas Energy Solutions
AESI
|
+$5.49M |
| 5 |
StoneX
SNEX
|
+$4.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.88% |
| 2 | Healthcare | 16.79% |
| 3 | Financials | 11.81% |
| 4 | Industrials | 8.02% |
| 5 | Communication Services | 7.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Johnson & Johnson
JNJ
$625B
| $315K | 0.04% |
1,700
| – | – |
|
102
Celestica
CLS
$36.5B
| $298K | 0.03% |
+1,210
| New | +$244K |
|
103
Aurora
AUR
$13.8B
| $283K | 0.03% |
52,500
-4,500
| -8% | -$26.4K |
|
104
Progressive
PGR
$125B
| $263K | 0.03% |
1,065
-1,409
| -57% | -$347K |
|
105
Eli Lilly
LLY
$1.06T
| $256K | 0.03% |
336
| – | – |
|
106
AT&T
T
$163B
| $248K | 0.03% |
8,770
| – | – |
|
|
BMNR
107
BitMine Immersion Technologies
BMNR
$11.4B
| $208K | 0.02% |
+4,000
| New | +$203K |
|
108
iShares Gold Trust
IAU
$67.5B
| $207K | 0.02% |
2,850
-1,288
| -31% | -$84K |
|
109
Research Solutions
RSSS
$72.2M
| $187K | 0.02% |
+50,000
| New | +$153K |
|
110
Global X NASDAQ-100 Covered Call ETF
QYLD
$8.26B
| $170K | 0.02% |
10,000
| – | – |
|
111
Adobe
ADBE
$105B
| – | – |
-3,381
| Closed | -$1.31M |
|
112
Dell
DELL
$293B
| – | – |
-6,503
| Closed | -$797K |
|
113
Equifax
EFX
$21.4B
| – | – |
-5,466
| Closed | -$1.42M |
|
114
Goosehead Insurance
GSHD
$2.32B
| – | – |
-27,658
| Closed | -$2.92M |
|
115
Medtronic
MDT
$112B
| – | – |
-16,824
| Closed | -$1.47M |
|
|
NVEE
116
DELISTED
NV5 Global
NVEE
| – | – |
-77,410
| Closed | -$1.79M |
|
|
AIOT
117
PowerFleet Inc
AIOT
$592M
| – | – |
-80,000
| Closed | -$345K |
|
Similar funds
RPAM
PS
BCM
RIM
GCM
AR
CL
AF
Ashford Capital Management's Q3 2025 Portfolio in Review
As of Q3 2025, Ashford Capital Management held 117 positions worth $898M, up 5.5% from $851M the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Ashford Capital Management's Q3 2025 filing shows 15 new, 24 increased, 44 reduced and 7 closed positions. Its largest new stake was Dutch Bros: 161,390 shares worth $8.45M. The largest sale was Ligand Pharmaceuticals, an estimated $8.64M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.
- Ashford Capital Management's largest Q3 2025 buy was Dutch Bros: 161,390 shares worth $8.45M.
- Ashford Capital Management added most to Cellebrite in Q3 2025, an estimated $6.83M increase.
- Ashford Capital Management's biggest Q3 2025 reduction was Ligand Pharmaceuticals, cutting an estimated $8.64M.
- Ashford Capital Management fully exited Goosehead Insurance in Q3 2025, selling an estimated $2.92M.
- Ashford Capital Management's ten largest holdings make up 37% of its $898M portfolio in Q3 2025.
- Ashford Capital Management opened 15 new positions and closed 7 in Q3 2025.
- Ashford Capital Management's portfolio value rose 5.5% quarter-over-quarter to $898M.
Based on Ashford Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.